Just spent 1 hour on the phone with the FDA, according to the very nice ladies I spoke with IND approval is complete on HemaXellerate. Also, Orphan drug status does not mean the clinical trials will take any less time. I spoke with the lady on the Orphan drug group and they have never heard of this drug. I called Bio-Matrix and left a message, nothing.